156 related articles for article (PubMed ID: 17524367)
1. The distribution of the DEK protein in mammalian chromatin.
Hu HG; Scholten I; Gruss C; Knippers R
Biochem Biophys Res Commun; 2007 Jul; 358(4):1008-14. PubMed ID: 17524367
[TBL] [Abstract][Full Text] [Related]
2. The DEK protein--an abundant and ubiquitous constituent of mammalian chromatin.
Waldmann T; Scholten I; Kappes F; Hu HG; Knippers R
Gene; 2004 Dec; 343(1):1-9. PubMed ID: 15563827
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK.
Kim DW; Chae JI; Kim JY; Pak JH; Koo DB; Bahk YY; Seo SB
J Cell Biochem; 2009 Apr; 106(6):1048-59. PubMed ID: 19229864
[TBL] [Abstract][Full Text] [Related]
4. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
[TBL] [Abstract][Full Text] [Related]
5. Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes.
Hu HG; Illges H; Gruss C; Knippers R
Int Immunol; 2005 Jun; 17(6):789-96. PubMed ID: 15908448
[TBL] [Abstract][Full Text] [Related]
6. The SAF-box domain of chromatin protein DEK.
Böhm F; Kappes F; Scholten I; Richter N; Matsuo H; Knippers R; Waldmann T
Nucleic Acids Res; 2005; 33(3):1101-10. PubMed ID: 15722484
[TBL] [Abstract][Full Text] [Related]
7. Functional domains of the ubiquitous chromatin protein DEK.
Kappes F; Scholten I; Richter N; Gruss C; Waldmann T
Mol Cell Biol; 2004 Jul; 24(13):6000-10. PubMed ID: 15199153
[TBL] [Abstract][Full Text] [Related]
8. Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition.
Lee KS; Kim DW; Kim JY; Choo JK; Yu K; Seo SB
J Cell Biochem; 2008 Mar; 103(4):1283-93. PubMed ID: 17685435
[TBL] [Abstract][Full Text] [Related]
9. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
[TBL] [Abstract][Full Text] [Related]
10. The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.
Deutzmann A; Ganz M; Schönenberger F; Vervoorts J; Kappes F; Ferrando-May E
Oncogene; 2015 Aug; 34(32):4270-7. PubMed ID: 25347734
[TBL] [Abstract][Full Text] [Related]
11. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.
Kappes F; Damoc C; Knippers R; Przybylski M; Pinna LA; Gruss C
Mol Cell Biol; 2004 Jul; 24(13):6011-20. PubMed ID: 15199154
[TBL] [Abstract][Full Text] [Related]
13. The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK.
Ageberg M; Gullberg U; Lindmark A
Haematologica; 2006 Feb; 91(2):268-9. PubMed ID: 16461319
[TBL] [Abstract][Full Text] [Related]
14. Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.
Karam M; Thenoz M; Capraro V; Robin JP; Pinatel C; Lancon A; Galia P; Sibon D; Thomas X; Ducastelle-Lepretre S; Nicolini F; El-Hamri M; Chelghoun Y; Wattel E; Mortreux F
Neoplasia; 2014 Jan; 16(1):21-30. PubMed ID: 24563617
[TBL] [Abstract][Full Text] [Related]
15. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
[TBL] [Abstract][Full Text] [Related]
16. Expression and isotopic labeling of structural domains of the human protein DEK.
Devany M; Kotharu NP; Matsuo H
Protein Expr Purif; 2005 Apr; 40(2):244-7. PubMed ID: 15766865
[TBL] [Abstract][Full Text] [Related]
17. DEK over-expression promotes mitotic defects and micronucleus formation.
Matrka MC; Hennigan RF; Kappes F; DeLay ML; Lambert PF; Aronow BJ; Wells SI
Cell Cycle; 2015; 14(24):3939-53. PubMed ID: 25945971
[TBL] [Abstract][Full Text] [Related]
18. Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells.
Khobta A; Ferri F; Lotito L; Montecucco A; Rossi R; Capranico G
J Mol Biol; 2006 Mar; 357(1):127-38. PubMed ID: 16427078
[TBL] [Abstract][Full Text] [Related]
19. SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery.
Gamble MJ; Fisher RP
Nat Struct Mol Biol; 2007 Jun; 14(6):548-55. PubMed ID: 17529993
[TBL] [Abstract][Full Text] [Related]
20. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
